Reflection Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Reflection Asset Management's BMY Position: Q1 2026 in Review
Reflection Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 1,978 shares — an estimated $107K sold.
Reflection Asset Management first reported a position in BMY in Q4 2025 and held it in 1 quarter. The position peaked at $107K in Q4 2025. 2,543 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Reflection Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Reflection Asset Management sold 1,978 Bristol-Myers Squibb shares in Q1 2026, an estimated $107K.
- Reflection Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 1 quarter.
- Reflection Asset Management's Bristol-Myers Squibb position peaked at $107K in Q4 2025.
- 2,543 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.